Groundbreaking results from a six-year clinical trial investigating treatment for hemorrhagic strokes, led by researchers at Emory University School of Medicine, show the minimally invasive approach under study is safe and superior to the current standard of care, marking a major advancement in the treatment of intracerebral hemorrhage (ICH), the deadliest form of stroke.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
